Fonseca R - Search Results

1

Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myeloma.

Van Wier S, Braggio E, Baker A, Ahmann G, Levy J, Carpten JD, Fonseca R. Van Wier S, et al. Among authors: fonseca r. Haematologica. 2013 Oct;98(10):1586-92. doi: 10.3324/haematol.2012.081083. Epub 2013 May 28. Haematologica. 2013. PMID: 23716545 Free PMC article.

2

Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma.

Fonseca R, Hoyer JD, Aguayo P, Jalal SM, Ahmann GJ, Rajkumar SV, Witzig TE, Lacy MQ, Dispenzieri A, Gertz MA, Kyle RA, Greipp PR. Fonseca R, et al. Leuk Lymphoma. 1999 Nov;35(5-6):599-605. doi: 10.1080/10428199909169625. Leuk Lymphoma. 1999. PMID: 10609798

3

Cytogenetic abnormalities in multiple myeloma.

Fonseca R, Coignet LJ, Dewald GW. Fonseca R, et al. Hematol Oncol Clin North Am. 1999 Dec;13(6):1169-80, viii. doi: 10.1016/s0889-8588(05)70119-2. Hematol Oncol Clin North Am. 1999. PMID: 10626143 Review.

4

Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.

Schop RF, Jalal SM, Van Wier SA, Ahmann GJ, Bailey RJ, Kyle RA, Greipp PR, Rajkumar SV, Gertz MA, Lust JA, Lacy MQ, Dispenzieri A, Witzig TE, Fonseca R. Schop RF, et al. Among authors: fonseca r. Cancer Genet Cytogenet. 2002 Jan 1;132(1):55-60. doi: 10.1016/s0165-4608(01)00526-x. Cancer Genet Cytogenet. 2002. PMID: 11801310

5

Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.

Fonseca R, Harrington D, Oken MM, Dewald GW, Bailey RJ, Van Wier SA, Henderson KJ, Blood EA, Rajkumar SV, Kay NE, Van Ness B, Greipp PR. Fonseca R, et al. Cancer Res. 2002 Feb 1;62(3):715-20. Cancer Res. 2002. PMID: 11830525

6

Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.

Fonseca R, Blood EA, Oken MM, Kyle RA, Dewald GW, Bailey RJ, Van Wier SA, Henderson KJ, Hoyer JD, Harrington D, Kay NE, Van Ness B, Greipp PR. Fonseca R, et al. Blood. 2002 May 15;99(10):3735-41. doi: 10.1182/blood.v99.10.3735. Blood. 2002. PMID: 11986230 Free article.

7

Genomic abnormalities in monoclonal gammopathy of undetermined significance.

Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA, Kyle RA, Gertz MA, Greipp PR, Dewald GW. Fonseca R, et al. Blood. 2002 Aug 15;100(4):1417-24. Blood. 2002. PMID: 12149226 Free article.

8

Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.

Schop RF, Kuehl WM, Van Wier SA, Ahmann GJ, Price-Troska T, Bailey RJ, Jalal SM, Qi Y, Kyle RA, Greipp PR, Fonseca R. Schop RF, et al. Among authors: fonseca r. Blood. 2002 Oct 15;100(8):2996-3001. doi: 10.1182/blood.V100.8.2996. Blood. 2002. PMID: 12351413 Free article.

9

Clinical and biologic implications of recurrent genomic aberrations in myeloma.

Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA, Dewald GW, Van Ness B, Van Wier SA, Henderson KJ, Bailey RJ, Greipp PR. Fonseca R, et al. Blood. 2003 Jun 1;101(11):4569-75. doi: 10.1182/blood-2002-10-3017. Epub 2003 Feb 6. Blood. 2003. PMID: 12576322 Free article.

10

Assays for neoplastic cell enrichment in bone marrow samples.

Fonseca R, Ahmann GJ. Fonseca R, et al. Methods Mol Med. 2003;85:333-42. doi: 10.1385/1-59259-380-1:333. Methods Mol Med. 2003. PMID: 12710218 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,483 results

Search Page

Filters